{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products BENZ Reagent",
        "VITROS Chemistry Products Calibrator Kit 26",
        "VITROS Chemistry Products FS Calibrator 1",
        "VITROS Chemistry Products DAT Performance Verifiers I",
        "VITROS Chemistry Products DAT Performance Verifiers II",
        "VITROS Chemistry Products DAT Performance Verifiers III",
        "VITROS Chemistry Products DAT Performance Verifiers IV",
        "VITROS Chemistry Products DAT Performance Verifiers V"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K062285",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993985",
        "K022707"
    ],
    "Regulatory Class": "",
    "Product Code(s)": [
        "JXM",
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "December 14, 2006",
    "Summary Letter Received Date": "December 15, 2006",
    "Submission Date": "August 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.3170",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine test system",
        "Clinical toxicology calibrators",
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzodiazepines",
        "Cocaine metabolites (benzoylecgonine)",
        "Methadone",
        "Amphetamines (d-methamphetamine)",
        "Opiates (morphine)",
        "Cannabinoids (11-nor-delta-THC-9-COOH)",
        "Phencyclidine",
        "Barbiturates (secobarbital)"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 5,1 FS Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Spectrophotometry (340 nm)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS BENZ Reagent, calibrator kits and performance verifiers for semi-quantitative or qualitative determination of benzodiazepines and other drugs of abuse in human urine using automated clinical chemistry analyzers",
    "Indications for Use Summary": "For in vitro diagnostic use to semi-quantitatively or qualitatively determine benzodiazepines in human urine, aiding in diagnosis and treatment of benzodiazepine use or overdose, and for calibration and performance monitoring of urine drugs of abuse assays on VITROS 5,1 FS Chemistry Systems",
    "fda_folder": "Toxicology"
}